Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
A series of sixteen ring-substituted -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against , three methicillin-resistant strains, H37Ra, , and . Several of the tested compounds showed antistaphylococcal, antitubercular, an...
Saved in:
Published in: | International journal of molecular sciences Vol. 19; no. 8; p. 2318 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
MDPI AG
07-08-2018
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | A series of sixteen ring-substituted
-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against
, three methicillin-resistant
strains,
H37Ra,
, and
. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2
)-
-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2
)-3-phenyl-
-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against
. These compounds showed an activity against biofilm formation of
ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2
)-
-(3,5-Dichlorophenyl)- and (2
)-
-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against
, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2
)-
-(3-Fluorophenyl)- and (2
)-
-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against
.
. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (
L.) chloroplasts. (2
)-
-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC
= 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against
var. Samsun. The structure⁻activity relationships are discussed. |
---|---|
AbstractList | A series of sixteen ring-substituted
-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against
, three methicillin-resistant
strains,
H37Ra,
, and
. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2
)-
-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2
)-3-phenyl-
-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against
. These compounds showed an activity against biofilm formation of
ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2
)-
-(3,5-Dichlorophenyl)- and (2
)-
-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against
, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2
)-
-(3-Fluorophenyl)- and (2
)-
-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against
.
. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (
L.) chloroplasts. (2
)-
-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC
= 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against
var. Samsun. The structure⁻activity relationships are discussed. A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure-activity relationships are discussed. A series of sixteen ring-substituted N -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus , three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum , and Bipolaris sorokiniana . Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2 E )- N -[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2 E )-3-phenyl- N -[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis . These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2 E )- N -(3,5-Dichlorophenyl)- and (2 E )- N -(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis , while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2 E )- N -(3-Fluorophenyl)- and (2 E )- N -(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B . sorokiniana . The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach ( Spinacia oleracea L.) chloroplasts. (2 E )- N -(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC 50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed. : A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed. : A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M.tuberculosis. These compounds showed an activity against biofilm formation of S.aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC50 = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure⁻activity relationships are discussed. |
Author | Kapustikova, Iva Moricz, Agnes M Strharsky, Tomas Pospisilova, Sarka Michnova, Hana Bakonyi, Jozsef Kollar, Peter Jampilek, Josef Oravec, Michal Cizek, Alois Kos, Jiri Kauerova, Tereza |
AuthorAffiliation | 4 Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary; moricz.agnes@agrar.mta.hu (A.M.M.); bakonyi.jozsef@agrar.mta.hu (J.B.) 3 Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic; oravec.m@czechglobe.cz 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia; sharka.pospisilova@gmail.com (S.P.); michnova.hana@gmail.com (H.M.); kapustikova@fpharm.uniba.sk (I.K.); strharsky2@uniba.sk (T.S.); josef.jampilek@gmail.com (J.J.) 2 Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; cizeka@vfu.cz 5 Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; tereza.kauerova@gmail.com (T.K.); |
AuthorAffiliation_xml | – name: 2 Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; cizeka@vfu.cz – name: 3 Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic; oravec.m@czechglobe.cz – name: 4 Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary; moricz.agnes@agrar.mta.hu (A.M.M.); bakonyi.jozsef@agrar.mta.hu (J.B.) – name: 5 Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic; tereza.kauerova@gmail.com (T.K.); kollarp@vfu.cz (P.K.) – name: 1 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia; sharka.pospisilova@gmail.com (S.P.); michnova.hana@gmail.com (H.M.); kapustikova@fpharm.uniba.sk (I.K.); strharsky2@uniba.sk (T.S.); josef.jampilek@gmail.com (J.J.) |
Author_xml | – sequence: 1 givenname: Sarka surname: Pospisilova fullname: Pospisilova, Sarka email: sharka.pospisilova@gmail.com, sharka.pospisilova@gmail.com organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. sharka.pospisilova@gmail.com – sequence: 2 givenname: Jiri surname: Kos fullname: Kos, Jiri email: jirikos85@gmail.com organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. jirikos85@gmail.com – sequence: 3 givenname: Hana surname: Michnova fullname: Michnova, Hana email: michnova.hana@gmail.com, michnova.hana@gmail.com organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. michnova.hana@gmail.com – sequence: 4 givenname: Iva surname: Kapustikova fullname: Kapustikova, Iva email: kapustikova@fpharm.uniba.sk organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. kapustikova@fpharm.uniba.sk – sequence: 5 givenname: Tomas surname: Strharsky fullname: Strharsky, Tomas email: strharsky2@uniba.sk organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. strharsky2@uniba.sk – sequence: 6 givenname: Michal surname: Oravec fullname: Oravec, Michal email: oravec.m@czechglobe.cz organization: Global Change Research Institute CAS, Belidla 986/4a, 60300 Brno, Czech Republic. oravec.m@czechglobe.cz – sequence: 7 givenname: Agnes M surname: Moricz fullname: Moricz, Agnes M email: moricz.agnes@agrar.mta.hu organization: Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary. moricz.agnes@agrar.mta.hu – sequence: 8 givenname: Jozsef surname: Bakonyi fullname: Bakonyi, Jozsef email: bakonyi.jozsef@agrar.mta.hu organization: Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Otto Str. 15, 1022 Budapest, Hungary. bakonyi.jozsef@agrar.mta.hu – sequence: 9 givenname: Tereza surname: Kauerova fullname: Kauerova, Tereza email: tereza.kauerova@gmail.com organization: Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. tereza.kauerova@gmail.com – sequence: 10 givenname: Peter surname: Kollar fullname: Kollar, Peter email: kollarp@vfu.cz organization: Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. kollarp@vfu.cz – sequence: 11 givenname: Alois surname: Cizek fullname: Cizek, Alois email: cizeka@vfu.cz organization: Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic. cizeka@vfu.cz – sequence: 12 givenname: Josef orcidid: 0000-0003-2003-9052 surname: Jampilek fullname: Jampilek, Josef email: josef.jampilek@gmail.com organization: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojarov 10, 83232 Bratislava, Slovakia. josef.jampilek@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30087309$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkUtv1DAURi1URB-wY40isWFBwK849gaprWipqMqisLZs53rqUWIPdjJS_z0uU6opKz_u0bnX_o7RQUwREHpL8CfGFP4c1lMhCkvKiHyBjgintMVY9Ad7-0N0XMoaY8pop16hQ4ax7BlWR-j77X2c76CE0pg4NLcbcHNepib55iykMa2CM2Nz6uawDXOA8lC4SVsYm5vW5PvRhRjNZKYwQHmNXnozFnjzuJ6gXxdff55_a69_XF6dn163jvdybh3hXkopBi-s5M5whW1vGHXOK8nBKeeFdJj0lLF6Zp0drMKMcqcs7z1lJ-hq5x2SWetNDlOdRCcT9N-LlFfa5Dm4ETQF6LnjFgTvOBhlPeEYD1bITnglhur6snNtFjvB4CDO2YzPpM8rMdzpVdpqQSjhXVcFHx4FOf1eoMx6CsXBOJoIaSma4tpKyJ7wir7_D12nJcf6VZoSLCWVQqlKfdxRLqdSMvinYQjWD4nr_cQr_m7_AU_wv4jZH7N2qQM |
CitedBy_id | crossref_primary_10_1002_chem_202301244 crossref_primary_10_3390_ijms20071524 crossref_primary_10_3390_ijms21186583 crossref_primary_10_3390_ijms23063159 crossref_primary_10_1080_10406638_2023_2212106 crossref_primary_10_3390_ijms232315090 crossref_primary_10_1080_17460441_2022_2097659 crossref_primary_10_3390_molecules25184121 crossref_primary_10_3390_ijms24043611 crossref_primary_10_52711_0974_360X_2022_00647 crossref_primary_10_3390_molecules24244531 crossref_primary_10_3390_antibiotics9020064 crossref_primary_10_3390_molecules27227799 crossref_primary_10_3390_ijms20040830 crossref_primary_10_1016_j_drudis_2022_05_006 crossref_primary_10_1016_j_ejmech_2021_113187 crossref_primary_10_2174_1389203720666190913114041 crossref_primary_10_1016_j_bioorg_2020_104060 crossref_primary_10_3390_ijms20215385 crossref_primary_10_1016_j_molstruc_2020_127813 crossref_primary_10_3390_pharmaceutics14122681 crossref_primary_10_1134_S1070428021040102 crossref_primary_10_3390_ma15072388 crossref_primary_10_1016_j_ejmech_2021_113735 crossref_primary_10_1016_j_heliyon_2024_e29051 crossref_primary_10_3390_app11104691 |
Cites_doi | 10.1016/S0732-8893(02)00473-X 10.1099/jmm.0.022426-0 10.1016/S0176-1617(98)80142-9 10.2174/138955712801264792 10.3390/molecules17010613 10.1128/AEM.68.4.1561-1568.2002 10.1016/j.bmcl.2016.07.021 10.1111/jam.12417 10.1186/1471-2180-8-149 10.1371/journal.pone.0176189 10.1016/j.bmc.2012.10.007 10.3390/molecules22081247 10.3390/molecules23051187 10.1002/ps.782 10.3390/molecules15118122 10.3390/molecules22101709 10.1016/j.jksus.2018.02.005 10.5301/ijao.5000027 10.1614/WS-09-102.1 10.1021/acsmedchemlett.7b00196 10.1021/jm101510d 10.1016/j.bmcl.2016.10.091 10.1111/j.1472-765X.2006.02001.x 10.1016/j.bmc.2015.06.047 10.3390/molecules20069767 10.1016/S0076-6879(80)69041-7 10.1016/S0377-8401(98)00278-8 10.3109/13880209.2010.519390 10.1016/j.drudis.2014.08.010 10.1016/j.bmcl.2017.03.050 10.1371/journal.pone.0149317 10.1093/mp/ssp106 10.3390/molecules18089397 10.3390/molecules19079655 10.1371/journal.pone.0002375 10.1111/j.1472-765X.2011.03122.x 10.1007/s00044-012-0093-z 10.1002/jhet.2670 10.3390/molecules191220197 10.1016/j.bmc.2015.03.018 10.1021/np50019a001 10.1155/2015/349534 10.1128/AAC.40.5.1274 10.1002/jobm.201000221 10.1016/j.drudis.2006.07.002 10.3390/microorganisms1010188 10.1104/pp.36.6.788 10.1038/nrd4001 10.1016/j.ijfoodmicro.2014.11.028 10.2174/1381612820666140905114627 10.1016/j.ijfoodmicro.2015.02.009 10.1080/14786419.2017.1317776 10.1128/AEM.00875-09 10.1016/j.ejmech.2010.01.024 10.1007/978-1-4939-1441-8_26 10.1016/j.ijfoodmicro.2006.04.046 10.3390/molecules191219292 10.1517/17460441.2016.1110142 10.1021/jf980154m 10.3390/molecules21081068 10.2174/1871520615666150130111120 10.1016/0005-2728(77)90157-8 10.3390/ijms17081219 10.1016/j.ejps.2011.04.012 10.1021/la303286v 10.2174/1573406410666140815125004 10.1016/j.bmcl.2018.05.011 10.1080/14756360902779326 10.1016/j.bmc.2013.08.030 10.33073/pjm-2011-005 10.1016/j.ejps.2015.06.009 10.1111/1462-2920.12213 10.3109/1040841X.2013.763219 |
ContentType | Journal Article |
Copyright | 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2018 by the authors. 2018 |
Copyright_xml | – notice: 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2018 by the authors. 2018 |
DBID | NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PIMPY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.3390/ijms19082318 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Research Library Research Library (Corporate) Access via ProQuest (Open Access) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | oai_doaj_org_article_2ee74c4be6454ea9bf1400db6856f96d 10_3390_ijms19082318 30087309 |
Genre | Journal Article |
GroupedDBID | --- 29J 2WC 3V. 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH ABDBF ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESTFP ESX F5P FRP FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HH5 HMCUK HYE IAO IPNFZ ITC KB. KQ8 LK8 M1P M2O M48 M7P MODMG M~E NPM O5R O5S OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 TUS UKHRP ~8M AAYXX CITATION 7XB 8FK K9. MBDVC PQEST PQUKI PRINS Q9U 7X8 5PM AFPKN |
ID | FETCH-LOGICAL-c478t-c14f8886df6b84ca490b7a32ccf984ec9cf68c01723384e35bdb90324c9b47f23 |
IEDL.DBID | RPM |
ISSN | 1422-0067 1661-6596 |
IngestDate | Tue Oct 22 15:15:37 EDT 2024 Tue Sep 17 21:10:40 EDT 2024 Fri Oct 25 08:18:34 EDT 2024 Thu Oct 10 16:48:57 EDT 2024 Thu Nov 21 20:59:43 EST 2024 Wed Oct 16 00:58:58 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | cinnamamides toxicity time-kill assay antistaphylococcal activity biofilm structure–activity relationship antitubercular activity PET inhibition MTT assay antifungal activity |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-c14f8886df6b84ca490b7a32ccf984ec9cf68c01723384e35bdb90324c9b47f23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2003-9052 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/ |
PMID | 30087309 |
PQID | 2108828699 |
PQPubID | 2032341 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2ee74c4be6454ea9bf1400db6856f96d pubmedcentral_primary_oai_pubmedcentral_nih_gov_6121455 proquest_miscellaneous_2085668714 proquest_journals_2108828699 crossref_primary_10_3390_ijms19082318 pubmed_primary_30087309 |
PublicationCentury | 2000 |
PublicationDate | 2018-08-07 |
PublicationDateYYYYMMDD | 2018-08-07 |
PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-07 day: 07 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationTitleAlternate | Int J Mol Sci |
PublicationYear | 2018 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | ref13 ref57 ref12 ref56 Kralova (ref95) 1992; 46 ref15 ref14 ref58 ref53 ref52 ref10 ref54 ref17 ref16 ref19 Abate (ref92) 1998; 2 Szabo (ref88) 2008; 52 Kralova (ref84) 1992; 11 Tortora (ref77) 2010 De (ref69) 2012 ref51 ref50 ref90 ref46 ref45 ref89 ref48 ref47 ref42 (ref91) 2012 ref44 ref43 ref49 ref8 ref7 ref9 ref3 ref6 ref82 ref81 ref40 ref83 Pliska (ref36) 1996; Volume 4 Kralova (ref87) 1995; 50 De Lucca (ref93) 1996; 40 ref80 Berrin (ref4) 2011; 49 ref35 ref79 ref34 ref78 ref37 ref31 ref75 ref30 ref33 ref32 ref76 ref2 ref1 ref39 ref38 Kralova (ref85) 1994; 49 Masarovicova (ref94) 2005 (ref18) 2017 Trebst (ref22) 1979 Izawa (ref24) 1980; Volume 69 Saari (ref74) 1998 ref71 ref70 Bueno (ref59) 2012 Hadjipavlou-Litina (ref11) 2015; 1208 ref72 Bowyer (ref23) 1991; Volume 10 ref68 ref67 ref26 ref25 Sharma (ref5) 2011; 3 ref20 ref64 Schwalbe (ref41) 2007 ref63 ref66 ref21 ref65 Kralova (ref86) 1994; 49 ref28 ref27 ref29 Budzynska (ref55) 2011; 60 ref60 ref62 Krishnendu (ref73) 2011; 5 ref61 |
References_xml | – ident: ref42 doi: 10.1016/S0732-8893(02)00473-X – ident: ref47 doi: 10.1099/jmm.0.022426-0 – ident: ref1 doi: 10.1016/S0176-1617(98)80142-9 – ident: ref6 doi: 10.2174/138955712801264792 – ident: ref19 doi: 10.3390/molecules17010613 – ident: ref44 doi: 10.1128/AEM.68.4.1561-1568.2002 – ident: ref81 doi: 10.1016/j.bmcl.2016.07.021 – ident: ref7 doi: 10.1111/jam.12417 – ident: ref49 doi: 10.1186/1471-2180-8-149 – ident: ref72 doi: 10.1371/journal.pone.0176189 – ident: ref82 doi: 10.1016/j.bmc.2012.10.007 – volume: 46 start-page: 348 year: 1992 ident: ref95 article-title: Photosynthesis inhibition produced by 2-alkylthio-6-R-benzothiazoles publication-title: Chem. Pap. contributor: fullname: Kralova – ident: ref14 doi: 10.3390/molecules22081247 – volume: 49 start-page: 857 year: 1994 ident: ref86 article-title: Correlation between biological activity and the structure of N,N’-bis(alkyldimethyl)-1,6-hexanediammonium dibromides. Antibacterial activity and inhibition of photochemical activity of chloroplasts publication-title: Pharmazie contributor: fullname: Kralova – volume: Volume 4 year: 1996 ident: ref36 article-title: Methods and Principles in Medicinal Chemistry contributor: fullname: Pliska – ident: ref16 doi: 10.3390/molecules23051187 – ident: ref31 doi: 10.1002/ps.782 – ident: ref26 doi: 10.3390/molecules15118122 – ident: ref17 – ident: ref30 doi: 10.3390/molecules22101709 – ident: ref70 doi: 10.1016/j.jksus.2018.02.005 – ident: ref56 doi: 10.5301/ijao.5000027 – ident: ref33 doi: 10.1614/WS-09-102.1 – ident: ref66 doi: 10.1021/acsmedchemlett.7b00196 – ident: ref68 doi: 10.1021/jm101510d – ident: ref13 doi: 10.1016/j.bmcl.2016.10.091 – volume: 2 start-page: 1011 year: 1998 ident: ref92 article-title: Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis publication-title: Int. J. Tuberc. Lung Dis. contributor: fullname: Abate – ident: ref53 doi: 10.1111/j.1472-765X.2006.02001.x – ident: ref60 doi: 10.1016/j.bmc.2015.06.047 – ident: ref61 doi: 10.3390/molecules20069767 – volume: Volume 69 start-page: 413 year: 1980 ident: ref24 article-title: Acceptors and donors for chloroplast electron transport doi: 10.1016/S0076-6879(80)69041-7 contributor: fullname: Izawa – ident: ref76 doi: 10.1016/S0377-8401(98)00278-8 – volume: 49 start-page: 396 year: 2011 ident: ref4 article-title: Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids publication-title: Pharm. Biol. doi: 10.3109/13880209.2010.519390 contributor: fullname: Berrin – ident: ref34 doi: 10.1016/j.drudis.2014.08.010 – ident: ref29 doi: 10.1016/j.bmcl.2017.03.050 – ident: ref90 doi: 10.1371/journal.pone.0149317 – ident: ref2 doi: 10.1093/mp/ssp106 – ident: ref83 doi: 10.3390/molecules18089397 – volume: Volume 10 start-page: 27 year: 1991 ident: ref23 contributor: fullname: Bowyer – volume: 11 start-page: 261 year: 1992 ident: ref84 article-title: Inhibitory effect of piperidinoethylesters of alkoxyphenylcarbamic acids on photosynthesis publication-title: Gen. Physiol. Biophys. contributor: fullname: Kralova – ident: ref10 doi: 10.3390/molecules19079655 – start-page: 617 year: 2005 ident: ref94 article-title: Approaches to Measuring Plant Photosynthesis Activity contributor: fullname: Masarovicova – ident: ref58 doi: 10.1371/journal.pone.0002375 – ident: ref51 doi: 10.1111/j.1472-765X.2011.03122.x – ident: ref89 doi: 10.1007/s00044-012-0093-z – start-page: 37 year: 1998 ident: ref74 article-title: Leaf blight disease and associated soil borne fungal pathogens of wheat in South and Southeast Asia contributor: fullname: Saari – ident: ref65 doi: 10.1002/jhet.2670 – ident: ref9 doi: 10.3390/molecules191220197 – ident: ref20 doi: 10.1016/j.bmc.2015.03.018 – ident: ref80 doi: 10.1021/np50019a001 – ident: ref37 doi: 10.1155/2015/349534 – volume: 40 start-page: 1274 year: 1996 ident: ref93 article-title: N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp. publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.40.5.1274 contributor: fullname: De Lucca – ident: ref57 doi: 10.1002/jobm.201000221 – volume: 49 start-page: 460 year: 1994 ident: ref85 article-title: Correlation between biological activity and the structure of 6-amino-2-R-thiobenzothiazoles. Anti-yeast activity and inhibition of photochemical activity of chloroplasts publication-title: Pharmazie contributor: fullname: Kralova – ident: ref32 doi: 10.1016/j.drudis.2006.07.002 – ident: ref75 doi: 10.3390/microorganisms1010188 – ident: ref78 – ident: ref25 doi: 10.1104/pp.36.6.788 – ident: ref63 doi: 10.1038/nrd4001 – ident: ref48 doi: 10.1016/j.ijfoodmicro.2014.11.028 – ident: ref52 doi: 10.2174/1381612820666140905114627 – start-page: 337 year: 2012 ident: ref69 article-title: Cinnamic derivatives in tuberculosis contributor: fullname: De – start-page: 147 year: 2012 ident: ref59 article-title: Antitubercular in vitro drug discovery: Tools for begin the search contributor: fullname: Bueno – year: 2010 ident: ref77 contributor: fullname: Tortora – start-page: 223 year: 1979 ident: ref22 article-title: Structure activity correlations of recent herbicides in photosynthetic reactions contributor: fullname: Trebst – ident: ref71 doi: 10.1016/j.ijfoodmicro.2015.02.009 – volume: 50 start-page: 440 year: 1995 ident: ref87 article-title: Antifungal and antialgal activity of piperidinopropyl esters of alkoxy substituted phenylcarbamic acids publication-title: Pharmazie contributor: fullname: Kralova – ident: ref15 doi: 10.1080/14786419.2017.1317776 – ident: ref54 doi: 10.1128/AEM.00875-09 – ident: ref64 doi: 10.1016/j.ejmech.2010.01.024 – year: 2012 ident: ref91 – volume: 1208 start-page: 361 year: 2015 ident: ref11 article-title: Aryl-acetic and cinnamic acids as lipoxygenase inhibitors with antioxidant, anti-inflammatory, and anticancer activity publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-1441-8_26 contributor: fullname: Hadjipavlou-Litina – ident: ref45 doi: 10.1016/j.ijfoodmicro.2006.04.046 – ident: ref8 doi: 10.3390/molecules191219292 – ident: ref35 doi: 10.1517/17460441.2016.1110142 – ident: ref43 doi: 10.1021/jf980154m – ident: ref62 doi: 10.3390/molecules21081068 – ident: ref12 doi: 10.2174/1871520615666150130111120 – year: 2017 ident: ref18 – year: 2007 ident: ref41 contributor: fullname: Schwalbe – ident: ref21 doi: 10.1016/0005-2728(77)90157-8 – ident: ref79 doi: 10.3390/ijms17081219 – volume: 3 start-page: 403 year: 2011 ident: ref5 article-title: Cinnamic acid derivatives: A new chapter of various pharmacological activities publication-title: J. Chem. Pharm. Res. contributor: fullname: Sharma – ident: ref67 doi: 10.1016/j.ejps.2011.04.012 – ident: ref50 doi: 10.1021/la303286v – ident: ref28 doi: 10.2174/1573406410666140815125004 – ident: ref40 doi: 10.1016/j.bmcl.2018.05.011 – ident: ref3 doi: 10.1080/14756360902779326 – volume: 5 start-page: 1064 year: 2011 ident: ref73 article-title: Bipolaris sorokiniana’(Sacc.) Shoem.: The most destructive wheat fungal pathogen in the warmer areas publication-title: Aust. J. Crop Sci. contributor: fullname: Krishnendu – ident: ref27 doi: 10.1016/j.bmc.2013.08.030 – volume: 60 start-page: 35 year: 2011 ident: ref55 article-title: Antibiofilm activity of selected plant essential oils and their major components publication-title: Pol. J. Microbiol. doi: 10.33073/pjm-2011-005 contributor: fullname: Budzynska – ident: ref38 doi: 10.1016/j.ejps.2015.06.009 – volume: 52 start-page: 251 year: 2008 ident: ref88 article-title: Isolation and characterization of EBR specific induced chitinases from tobacco (Nicotiana tabacum) publication-title: Acta Biol. Szeged. contributor: fullname: Szabo – ident: ref39 doi: 10.1111/1462-2920.12213 – ident: ref46 doi: 10.3109/1040841X.2013.763219 |
SSID | ssj0023259 |
Score | 2.4037404 |
Snippet | A series of sixteen ring-substituted
-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was... : A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was... A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was... A series of sixteen ring-substituted N -arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 2318 |
SubjectTerms | Ampicillin Antibiotics Antifungal activity antistaphylococcal activity antitubercular activity Benomyl Biocompatibility biofilm Biofilms Chloroplasts cinnamamides Ciprofloxacin Cytotoxicity Drug resistance Electron transport Fungicides Isoniazid Metabolism Methicillin Minimum inhibitory concentration MTT assay PET inhibition Photosynthesis Spinach Staphylococcus aureus structure–activity relationship time-kill assay toxicity Tuberculosis Vancomycin |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-RAEC5UELyIb-OLCOsxmEl3-nH0iSDMRRe8hX5iFqdnMc7C_Hurk8wwIwtevKY70KmvK6mPVH8fwC9JlZOlJlnpNcuo1phShSoygxuA0dxwKeNB4YcnPnwRt3dRJmdu9RV7wjp54C5wl4VznBqqXZSeckpqj5Qgt5qJknnJbPv2zdmMTPVUi2BV37W5EyT1l_WfUTNozb2jucfCB6jV6f9fcfm1R3Lho3O_BZt9tZhedavchhUXdmC984-c7sLj0zRgAdfUTaqCTaOX_Mf7ZJSOfdrNiQikV6Z1iEBKHAeG43_uLR1m6n36ZuoQ1EiNauuaPfh9f_d885D17giZoVx8ZGZAPdJXZj3TghpFZa65IoUxXgrqjDSeCRMpHrJQ6kiprZY51k9Gasp9QfZhLYyDO4SUF0pYopX0ZUEx44VjclBwb3OqJGGDBC5mIav-diIYFZKHGNpqMbQJXMd4zudE6er2AgJa9YBW3wGawMkMjarPp6ZCiEU88C5lAufzYcyE-HtDBTee4BysHhlDAkgTOOjAm6-EROk9kuPdfAnWpaUuj4T6tVXbjhJrtCyPfuLZjmEDCy7RNhDyE1jDPeFOYbWxk7N2_34C7nv2kg priority: 102 providerName: Directory of Open Access Journals |
Title | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30087309 https://www.proquest.com/docview/2108828699 https://search.proquest.com/docview/2085668714 https://pubmed.ncbi.nlm.nih.gov/PMC6121455 https://doaj.org/article/2ee74c4be6454ea9bf1400db6856f96d |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7cguCLeDe2LhH0Md0kM5nLY60tleIiVMG3MFeNbCZl0xX23_fMJFl2xSdfMxMYzoX5vuSc7yD0XhBpRaVwVjlFM6IUpFQpy0xDAFCSayZEaBS-umHLH_zTRZDJqaZemFi0r1Vz6lftqW9-xdrK21Yvpjqxxdcv50H1ilTVYoZmgA0nij6yLAyAfqhwx8DnF83vti_iXO8izObDQYMNh_LDvWsoqvX_C2L-XSm5d_VcPkGPR8yYng1ne4oeWP8MPRymSG6fo-ubrQcY1zd9Kr1Jw0T5u_WmTTuXDnuCH9IzHedEADEOC8vuj12ly0yutyvdeC9b2TbG9i_Q98uLb-dX2TgjIdOE8btMF8QBiaXGUcWJlkTkiklcau0EJ1YL7SjXgegBFyUWV8ookQOK0kIR5kr8Eh35ztvXKGWl5AYrKVxVEsh7bqkoSuZMTqTAtEjQh8lk9e0ghVEDhQhWrvetnKCPwZ67PUHAOj7o1j_r0Y11aS0jmigbFMWsFMoB08uNoryiTlCToJPJG_WYVX0N9JSHtnchEvRutwz5EH5ySG-7DewBDEkp0ECSoFeD83YnmZyfIHbg1oOjHq5ACEbN7THk3vz3m8foEWAtHmsH2Qk6gkCwb9GsN5s5IPnP1_P4NWAeY_keFAj4Xg |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIgQX3o9AgSDBMd0kdvw4ltJqUdsVUovELbIdG4I23mrTRdp_zziP1S7i1GvGkSx_M_F8ysw3AB8lVVYWmiSF0yyhWmNI5SpPDDoAo6nhUoZG4ekln_0QX06CTE4x9sJ0RftG14d-3hz6-ldXW3ndmMlYJzb5dnEcVK9oUUz24C7Ga5qOJH3gWQRT-r7GnSCjn9S_mzbrJntnYTofCSpsJBQgbl1EnV7__5LMf2slty6f00e33PZjeDhkm_FRb34Cd6x_Cvf6-ZPrZ3B2ufaYALZ1GytfxWEW_c1y1cQLF_drAoLxkekmTCClDobZ4o-dx7NELddzU3uvGtXUlW2fw_fTk6vjaTJMV0gM5eImMRl1SH9Z5ZgW1CgqU80VyY1xUlBrpHFMmEARkcVSSwpdaZli_mWkptzl5AXs-4W3ryDmuRIV0Uq6Iqf4xRCWySznrkqpkoRlEXwaj7q87kU0SiQfAZ1yG50IPgccNmuC9HX3YLH8WQ4nWebWcmqotkGLzCqpHXLEtNJMFMxJVkVwMKJYDvHYlkhsRWiYlzKCDxszRlL4PaK8XaxwDWafjCGBpBG87EHf7GR0mgj4jjvsbHXXgl7QqXUPqL--9Zvv4f706uK8PP86O3sDDzBjE10FIj-AfXQK-xb22mr1rouBv3NqC_8 |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoEagX3tBAgSDBMc3Djh_H0nZVVFhVKkjcIj9L0MZZbbpI--8ZJ9nVLuIE13gijTwz8fcp428Qei-ItKJUOCmdoglRCkqqkEWiIQEoyTQTIlwUvrhm0-_87DzI5GxGffVN-1rVx37WHPv6R99bOW90uu4TS6--nAbVK1KW6dy4dA_dhZrNijVRH7kWBlg_9LljYPVp_bPp8n66dx4m9OGgxIZDE-LWYdRr9v8NaP7ZL7l1AE0e_ofrj9CDEXXGJ4PJY3TH-ifo3jCHcvUUXV6vPADBru5i6U0cZtLfLpZN3Lp4sAmRjE90P2kCqHVYmLa_7CyeJnKxmunae9nIpja2e4a-Tc6_nl4k45SFRBPGbxOdEwc0mBpHFSdaEpEpJnGhtROcWC20o1wHqghsllhcKqNEBjhMC0WYK_BztO9bbw9RzArJDVZSuLIg8OXgloq8YM5kRApM8wh9WG93NR_ENCogISFC1XaEIvQxxGJjEySw-wft4qYad7MqrGVEE2WDJpmVQjngiplRlJfUCWoidLSOZDXWZVcBweXh4rwQEXq3WYaKCr9JpLftEmwAhVIKRJJE6MUQ-I0n68SJENtJiR1Xd1cgE3rV7jHyL__5zbfo_tXZpPr8aXr5Ch0AcON9IyI7QvuQE_Y12uvM8k1fBr8B4VoOfw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+Spectrum+of+Biological+Activities+of+Novel+N-arylcinnamamides&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Pospisilova%2C+Sarka&rft.au=Kos%2C+Jiri&rft.au=Michnova%2C+Hana&rft.au=Kapustikova%2C+Iva&rft.date=2018-08-07&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=19&rft.issue=8&rft.spage=2318&rft_id=info:doi/10.3390%2Fijms19082318&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |